News & Updates

Targeted HCV micro-elimination enhances case finding and treatment
Targeted HCV micro-elimination enhances case finding and treatment
15 Nov 2021 byChristina Lau

A hepatitis C virus (HCV) micro-elimination programme targeting high-risk groups can enhance the effectiveness of screening and significantly shorten the time to starting direct-acting antiviral (DAA) therapy without compromising treatment outcomes, researchers at the University of Hong Kong (HKU) have reported.

Targeted HCV micro-elimination enhances case finding and treatment
15 Nov 2021
Double trouble: Alcohol-related liver diseases take a turn for the worse during COVID-19
Double trouble: Alcohol-related liver diseases take a turn for the worse during COVID-19
15 Nov 2021 byElvira Manzano

Higher intake of alcohol and reduced care during the COVID-19 pandemic have triggered a spike in alcohol-related liver diseases, leading to some serious consequences, according to new research.

Double trouble: Alcohol-related liver diseases take a turn for the worse during COVID-19
15 Nov 2021
Dietary acrylamide compromises physical performance in knee OA
Dietary acrylamide compromises physical performance in knee OA
14 Nov 2021

In people with knee osteoarthritis (OA) or are at high risk of such condition, dietary acrylamide seems to worsen physical performance and may potentially increase the risk of sarcopoenia, a recent study has found.

Dietary acrylamide compromises physical performance in knee OA
14 Nov 2021